Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients With Type 2 Diabetes Mellitus in the Kazakh Population

Enrolling by invitationOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

July 19, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2027

Conditions

Diabetes MellitusDiabetic Nephropathy

Interventions

GENETIC

glycation genes

DIAGNOSTIC_TEST

beta 2 microglobulin

b2m

Trial Locations (1)

AstanaMU, Astana

All Listed Sponsors

collaborator

Viamedis LLP

UNKNOWN

lead

Astana Medical University

OTHER